However, preclinical PET/CT studies in disease models with known MMP up-regulation (e.g., tumor, Lewis lung carcinoma bearing mice; atherosclerotic plaques, apolipoprotein E-deficient mice) should be assessed [87]. Here, APOE is linked to neoplasm.